论文部分内容阅读
目的了解宁波市鄞州区他汀类和贝特类调脂药物的使用情况。方法采用随机抽样方法,从鄞州区卫生信息平台抽取7个乡镇的高血压合并高脂血症患者用药信息及体检信息,并对他汀类和贝特类药物处方、患者血压及血脂资料进行分析。结果 2 024例高血压合并高脂血症患者,年龄以60~74岁为主(62.15%),女性患者占64.94%;含调脂药物处方7 523张,阿托伐他汀药物、辛伐他汀药物、非诺贝特药物处方百分率分别为33.38%、51.25%、15.37%,人均处方量分别为3.3、4.5和2.9张,日均费用分别为8.57、4.29和5.71元。结论鄞州区他汀类调脂药物使用高于贝特类,其中辛伐他汀分散片的用药频度最高,日均使用费用最低,是一种性价比较高的调脂药物。
Objective To understand the use of statins and fibrate lipid-lowering drugs in Yinzhou District of Ningbo City. Methods Random sampling method was used to extract medication information and physical examination information of patients with hypertension and hyperlipidemia in 7 towns and townships from Yinzhou District Health Information Platform. Statistic and fibrate prescriptions, blood pressure and blood lipid data were analyzed. Results A total of 2 024 patients with hypertension and hyperlipidemia were aged 60-74 years (62.15%) and female patients (64.94%). There were 7 523 prescriptions of lipid-lowering drugs, atorvastatin, simvastatin The prescriptions of drugs and fenofibrate were 33.38%, 51.25% and 15.37% respectively, and the prescriptions per capita were 3.3, 4.5 and 2.9 respectively. The daily average costs were 8.57, 4.29 and 5.71 yuan respectively. Conclusion Statin lipid-lowering drugs in Yinzhou District are higher than fibrates. Simvastatin dispersible tablets have the highest frequency of medication and the lowest average daily use cost, which is a cost-effective lipid-lowering drug.